Results 191 to 200 of about 12,982,238 (215)

Recombinant long‐acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials

Haemophilia, 2016
Claude Negrier, Guy Young, F. A. Karim, P. Collins, Hideji Hanabusa, T. Colberg, B. Goldman, Christopher E. Walsh   +7 more
semanticscholar   +1 more source

Haemophilia in Sweden

Acta Medica Scandinavica, 1962
Olof Ramgren, Margareta Blombäck, Irene Von Francken, Inga Marie Nilsson   +3 more
openaire   +2 more sources

Mutation analysis of Swedish haemophilia B families – high frequency of unique mutations

Haemophilia, 2016
A. Mårtensson, A. Letelier, C. Halldén, R. Ljung   +3 more
semanticscholar   +1 more source

Treatment of Haemophilia A and B

2015
openaire   +3 more sources

Canine Haemophilia B (Christinas Disease)

British Journal of Haematology, 1960
H. G. Downie, T. D. Hoeksema, G. A. Robinson, H. C. Rowsell, J F Mustard   +4 more
openaire   +3 more sources

ACQUIRED HAEMOPHILIA B

The Lancet, 1981
openaire   +2 more sources

Safety of bevacizumab in mild haemophilia B

Thrombosis and Haemostasis, 2008
Véronique Deneys, Catherine Lambert, Cedric Hermans, Dominique Pothen   +3 more
openaire   +3 more sources

Gene therapy for haemophilia B [PDF]

, 2020
Jian-Min Wang, Kotoku Kurachi
openaire   +1 more source

Improvement in health‐related quality of life in patients with haemophilia B treated with nonacog beta pegol, a new extended half‐life recombinant FIX product

Haemophilia, 2016
P. Chowdary, Susan Kearney, A. Regnault, C. Hoxer, D. L. Yee   +4 more
semanticscholar   +1 more source

UNUSUAL CASE OF HAEMOPHILIA B

The Lancet, 1989
George G. Brownlee, George G. Brownlee, George G. Brownlee, A. Black, A. Black, A. Black, P.M. Crossley, P.M. Crossley, P.M. Crossley, C.R. Rizza, C.R. Rizza, C.R. Rizza, P.R. Winship, P.R. Winship, P.R. Winship   +14 more
openaire   +2 more sources